WAILEA, Hawaii — Myopic choroidal neovascularization, a continuum of myopia and pathologic myopia, is a rare but treatable cause of vision loss, according to a speaker here.
Approximately 41,000 people in the U.S. have myopic choroidal neovascularization (CNV). People with pathologic myopia between the ages of 45 and 64 years, especially women, are more likely to develop myopic CNV, Rishi P. Singh, MD, said at Retina 2018.
“We’re learning more about the primary prevention strategies, and I think the numbers will hopefully improve due to those strategies. I use OCT
Uncategorized